日本の血液凝固検査市場

◆英語タイトル:New Frontiers in the Japanese Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape
◆発行会社/調査会社:Venture Planning Group
◆商品コード:VPCA8117
◆発行日:2014年5月
◆調査対象地域:日本
◆ページ数:※レポート概要をご参照ください。
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Local LicenseUSD7,400 ⇒換算¥814,000見積依頼/購入/質問フォーム
Global LicenseUSD16,300 ⇒換算¥1,793,000見積依頼/購入/質問フォーム
DataPackUSD4,800 ⇒換算¥528,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Venture Planning Group社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[日本の血液凝固検査市場]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Complete report $7,400.  DataPack (test volumes, sales forecasts, supplier shares) $4,800.  

New Frontiers in the Japanese Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the Japanese coagulation testing market during the next five years. 

The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the Japanese coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation.  Coagulation testing will also become more standardized, offering opportunities for quality control products and services.  Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Japanese Market Overview

- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers.

- Estimated universe of facilities performing coagulation tests.

- Five-year test volume and sales projections.

Business Opportunities and Strategic Recommendations

- Product development and business expansion
opportunities with significant market appeal.

- “Ideal” product models with tentative
prices and operating characteristics.

- Alternative market penetration
strategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.

Current and Emerging Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrand’s Factor Fav/Ag, and others.

Sales and Market Share Analysis of Instrument and Reagent Suppliers

- Sales and market shares of major instrument
and consumable manufactures.

Market Segmentation Analysis

- Comprehensive market
segmentation analysis, including: 

     – Hospitals
     – Commercial/Private Laboratories

- Test volume forecasts for over 40 major procedures,
by market segment.

Current and Emerging Products

- Review of established and new procedures.

- Comparison of automated and semi-automated
analyzers marketed by Diagnostica Stago, Helena, IL,
Roche, Siemens, Sysmex and other suppliers.

Technology Review 

- Analysis of current and emerging technologies
and their potential market applications.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms
developing innovative coagulation testing technologies
and products, including their sales, product portfolios,
marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

     – Abbott
     – ADI/American Diagnostica
     – Axis-Shield
     – Alere/Biosite/Inverness
     – Beckman Coulter/Danaher
     – Becton Dickinson
     – Bio/Data
     – Chrono-Log
     – Corgenix Medical
     – Diagnostica Stago/Trinity Biotech
     – Grifols
     – Helena Laboratories
     – Hyphen BioMed
     – Instrumentation Laboratory
     – ITC/Nexus Dx
     – Roche
     – Siemens
     – Sienco
     – Sysmex
     – Thermo Fisher
     – ZyCare/Alere

Contains 402 pages and 35 tables

*** レポート目次(コンテンツ)***

※目次は下記のURLでご確認ください。

http://www.vpgcorp.com/webfiles/Coagulation/TOCLOTNewFrontierintheJapaneseCoagulationTestingMarketChallengesEmergingTechCompetitiveLandscape.pdf



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(VPCA8117 )"日本の血液凝固検査市場" (英文:New Frontiers in the Japanese Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape )はVenture Planning Group社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。